The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10X GENOMICS INC | CL A COM | 88025U109 | 670,080 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | |||
2SEVENTY BIO INC | COM | 901384107 | 605,510 | 59,833 | SH | SOLE | 59,833 | 0 | 0 | |||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 5,973,130 | 249,400 | SH | SOLE | 249,400 | 0 | 0 | |||
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 1,824,434 | 2,252,388 | SH | SOLE | 2,252,388 | 0 | 0 | |||
ALKERMES PLC | SHS | G01767105 | 1,565,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 351,680 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 1,093,200 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | |||
ARVINAS INC | COM | 04335A105 | 372,300 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
ALPHATEC HOLDINGS INC | COM | 02081G201 | 1,438,400 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
AZIYO BIOLOGICS INC | COM | 05479K106 | 3,906,234 | 1,655,184 | SH | SOLE | 1,655,184 | 0 | 0 | |||
AXOGEN INC | COM | 05463X106 | 365,200 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 140,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
BIODESIX INC | COM | 09075X108 | 6,198,749 | 5,039,633 | SH | SOLE | 5,039,633 | 0 | 0 | |||
BLUEBIRD BIO INC | COM | 09609G100 | 819,868 | 249,200 | SH | SOLE | 249,200 | 0 | 0 | |||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 46,593,011 | 728,585 | SH | SOLE | 728,585 | 0 | 0 | |||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 576,300 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 1,112,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
CULLINAN ONCOLOGY INC | COM | 230031106 | 270,227 | 25,114 | SH | SOLE | 25,114 | 0 | 0 | |||
CYTOKINETICS INC | COM | 23282W605 | 815,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
DOCGO INC | COM | 256086109 | 1,030,700 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
EQUITRANS MIDSTREAM CORPORATIO | COM | 294600101 | 1,271,958 | 133,050 | SH | SOLE | 133,050 | 0 | 0 | |||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 1,864,495 | 264,843 | SH | SOLE | 264,843 | 0 | 0 | |||
G1 THERAPEUTICS INC | COM | 3621LQ109 | 99,600 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
GOSSAMER BIO INC | COM | 38341P102 | 118,906 | 99,088 | SH | SOLE | 99,088 | 0 | 0 | |||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 360,700 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
HARROW HEALTH INC | COM | 415858109 | 2,856,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
IMMUNOGEN INC | COM | 45253H101 | 3,585,300 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | |||
INFLARX NV | COM | N44821101 | 223,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
INHIBRX INC | COM | 45720L107 | 1,828,830 | 70,448 | SH | SOLE | 70,448 | 0 | 0 | |||
IVERIC BIO INC | COM | 46583P102 | 983,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 360,000 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 521,484 | 291,332 | SH | SOLE | 291,332 | 0 | 0 | |||
KEROS THERAPEUTICS INC | COM | 492327101 | 281,260 | 7,000 | SH | SOLE | 7,000 | 0 | 0 | |||
KINIKSA PHARMACEUTICALS LTD | COM | G5269C101 | 422,400 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
MASIMO CORP | COM | 574795100 | 2,514,324 | 15,280 | SH | SOLE | 15,280 | 0 | 0 | |||
NEKTAR THERAPEUTICS | COM | 640268108 | 16,106 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | |||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 7,943,832 | 84,240 | SH | SOLE | 84,240 | 0 | 0 | |||
OVINTIV INC | COM | 69047Q102 | 3,205,494 | 84,200 | SH | SOLE | 84,200 | 0 | 0 | |||
PHREESIA INC | COM | 71944F106 | 2,564,527 | 82,700 | SH | SOLE | 82,700 | 0 | 0 | |||
PIONEER NATURAL RESOURCES CO | COM | 723787107 | 787,284 | 3,800 | SH | SOLE | 3,800 | 0 | 0 | |||
PROGYNY INC | COM | 74340E103 | 354,060 | 9,000 | SH | SOLE | 9,000 | 0 | 0 | |||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 1,049,560 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | |||
PROTHENA CORP PLC | SHS | G72800108 | 10,659,259 | 156,111 | SH | SOLE | 156,111 | 0 | 0 | |||
QUIDELORTHO CORP | COM | 74838J101 | 5,402,721 | 65,203 | SH | SOLE | 65,203 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 286,300 | 2,500 | SH | SOLE | 2,500 | 0 | 0 | |||
SILK ROAD MEDICAL INC | COM | 82710M100 | 649,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
SOLENO THERAPEUTICS INC | COM | 834203101 | 1,051,593 | 245,127 | SH | SOLE | 245,127 | 0 | 0 | |||
STOKE THERAPEUTICS INC | COM | 86150R107 | 903,550 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 614,400 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 3,311,250 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 865,920 | 26,400 | SH | SOLE | 26,400 | 0 | 0 | |||
XENCOR INC | COM | 98401F105 | 307,131 | 12,300 | SH | SOLE | 12,300 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 385,000 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
YIELD10 BIOSCIENCE INC | COM | 98585K102 | 41,625 | 18,750 | SH | SOLE | 18,750 | 0 | 0 |